This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel therapeutic agents. It serves as a key intermediate in the creation of compounds targeting neurological disorders, such as anxiety and depression, due to its structural similarity to molecules that interact with central nervous system receptors. Additionally, it is explored for its potential in designing drugs that modulate enzyme activity, offering possibilities for treating inflammatory and metabolic diseases. Its application extends to preclinical studies, where it aids in understanding drug-receptor interactions and optimizing pharmacological properties for enhanced efficacy and safety.